These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24052607)

  • 1. Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer.
    Ferguson MK; Watson S; Johnson E; Vigneswaran WT
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):660-4. PubMed ID: 24052607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis.
    Eguchi T; Bains S; Lee MC; Tan KS; Hristov B; Buitrago DH; Bains MS; Downey RJ; Huang J; Isbell JM; Park BJ; Rusch VW; Jones DR; Adusumilli PS
    J Clin Oncol; 2017 Jan; 35(3):281-290. PubMed ID: 28095268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV₁ and diffusing capacity of the lung for carbon monoxide < 40%.
    Puente-Maestú L; Villar F; González-Casurrán G; Moreno N; Martínez Y; Simón C; Peñalver R; González-Aragoneses F
    Chest; 2011 Jun; 139(6):1430-1438. PubMed ID: 20930005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.
    Burt BM; Kosinski AS; Shrager JB; Onaitis MW; Weigel T
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):19-28, dicussion 28-29.e1. PubMed ID: 24766848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC).
    Almquist D; Khanal N; Smith L; Ganti AK
    Anticancer Res; 2018 May; 38(5):2903-2907. PubMed ID: 29715115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
    Ferguson MK; Vigneswaran WT
    Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung scintigraphy and ergospirometry in prediction of postoperative course in lung resection candidates with increased risk of postoperative complications].
    Bolliger CT; Wyser C; Roser H; Stulz P; Solèr M; Perruchoud AP
    Pneumologie; 1996 May; 50(5):334-41. PubMed ID: 8710817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicted versus observed FEV1 and DLCO after major lung resection: a prospective evaluation at different postoperative periods.
    Brunelli A; Refai M; Salati M; Xiumé F; Sabbatini A
    Ann Thorac Surg; 2007 Mar; 83(3):1134-9. PubMed ID: 17307474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.
    Kim ES; Kim YT; Kang CH; Park IK; Bae W; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1317-26. PubMed ID: 27366059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment.
    Magdeleinat P; Seguin A; Alifano M; Boubia S; Regnard JF
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1099-105. PubMed ID: 15896625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced vital capacity predicts long-term survival for curative-resected NSCLC.
    Guo X; Cao H; Xu J; Yu J; Zheng C; Meng L; Du J
    Med Oncol; 2014 Sep; 31(9):146. PubMed ID: 25099763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusing capacity predicts long-term survival after lung resection for cancer.
    Ferguson MK; Dignam JJ; Siddique J; Vigneswaran WT; Celauro AD
    Eur J Cardiothorac Surg; 2012 May; 41(5):e81-6. PubMed ID: 22368187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.
    Berry MF; Yang CJ; Hartwig MG; Tong BC; Harpole DH; D'Amico TA; Onaitis MW
    Ann Thorac Surg; 2015 Jul; 100(1):271-6. PubMed ID: 25986099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality.
    Pierce RJ; Copland JM; Sharpe K; Barter CE
    Am J Respir Crit Care Med; 1994 Oct; 150(4):947-55. PubMed ID: 7921468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications.
    Bolliger CT; Wyser C; Roser H; Solèr M; Perruchoud AP
    Chest; 1995 Aug; 108(2):341-8. PubMed ID: 7634864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lung resection on exercise capacity and on carbon monoxide diffusing capacity during exercise.
    Wang JS; Abboud RT; Wang LM
    Chest; 2006 Apr; 129(4):863-72. PubMed ID: 16608931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
    Takeda S; Funakoshi Y; Kadota Y; Koma M; Maeda H; Kawamura S; Matsubara Y
    Ann Thorac Surg; 2006 Jul; 82(1):232-6. PubMed ID: 16798220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer.
    Wang J; Olak J; Ferguson MK
    J Thorac Cardiovasc Surg; 1999 Mar; 117(3):581-6; discussion 586-7. PubMed ID: 10047663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.